Penas-Prado, M., Hess, K. R., Fisch, M. J., Lagrone, L. W., Groves, M. D., Levin, V. A., . . . Gilbert, M. R. (2015). Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol.
Chicago Style CitationPenas-Prado, Marta, et al. "Randomized Phase II Adjuvant Factorial Study of Dose-dense Temozolomide Alone and in Combination With Isotretinoin, Celecoxib, And/or Thalidomide for Glioblastoma." Neuro Oncol 2015.
Cita MLAPenas-Prado, Marta, et al. "Randomized Phase II Adjuvant Factorial Study of Dose-dense Temozolomide Alone and in Combination With Isotretinoin, Celecoxib, And/or Thalidomide for Glioblastoma." Neuro Oncol 2015.